Skip to content
Back to glossary
Biomarkers

Omega-3 index

DEOmega-3-Index

The Omega-3 index is a blood test. It is the combined amount of two omega-3 fats, EPA and DHA, as a percentage of all the fatty acids in your red-blood-cell membranes. Because red cells live about 120 days, the index reflects your average omega-3 intake over roughly 2 to 4 months. That is an advantage over plasma tests, which only capture recent diet. Harris and Von Schacky (2004) proposed it as a new risk marker for heart-disease death. They set a desirable zone at 8% or higher, and a high-risk zone at 4% or lower. Most adults in Western countries fall between 4% and 6%. Many prospective studies have found that a higher Omega-3 index goes with lower heart and all-cause death, on top of standard lipid risk factors. A 2007 review by Harris pulled this together and strengthened the case. The index is analytically standardized through a certified lab method. But it remains a risk marker, not a proven causal factor. Omega-3 supplement trials have given mixed heart results, so the link cannot yet be called conclusively causal in all populations.

Last reviewed:

This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer

Sources

  1. Harris WS, Von Schacky C. (2004). The Omega-3 Index: a new risk factor for death from coronary heart disease?. *Preventive Medicine*doi:10.1016/j.ypmed.2004.02.030
  2. Harris WS. (2007). Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. *Pharmacological Research*
  3. Franco WG, O'Keefe EL, O'Keefe JH, et al.. (2025). Omega-3 index improves upon the pooled cohort equation in predicting risk for CVD. *Journal of Clinical Lipidology*